Summary
M2 EQUITYBITES-July 12, 2011-Advaxis Inc enrols first 40 low dose subject cohort in ADXS-HPV trial of CIN
(C)1994-2011 M2 COMMUNICATIONS http://www.m2.comSee the full content of this document
Extract
Trial of Cin
Biotechnology company Advaxis Inc (...
See the full content of this document
Sponsored links
